Elucidating the beneficial effects of melphalan, adriamycin, and corticoids in combination with bortezomib against multiple myeloma in vitro
Crossref DOI link: https://doi.org/10.1007/s00210-018-01602-1
Published Online: 2018-12-15
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schäfer, Julia
Burhenne, Jürgen
Weiss, Johanna
Theile, Dirk http://orcid.org/0000-0003-4720-9242
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB/TRR79, subproject B10)
Text and Data Mining valid from 2018-12-15
Article History
Received: 8 October 2018
Accepted: 6 December 2018
First Online: 15 December 2018